Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions

PRESS RELEASE Amsterdam & Cardiff, 13 November 2023 Led by CEO Iestyn Foster, Amotio is on a mission to transform the way joint implant…

Read more

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted.

November, 2023, Amsterdam.  Sifted, the Financial Times’ platform for innovation and start-ups, named NLC as the most active early-stage healthcare investor in Europe. The…

Read more

CHECK OUT OUR LATEST VENTURE: ChARM

PRESS RELEASE Amsterdam, 07/11/2023   ChARM is making waves in the realm of pneumonia diagnosis. This precision-focused heart monitor is ready to redefine the…

Read more

INTRODUCING OUR NEWEST VENTURE: ASCLEPIUS

PRESS RELEASE 31 October 2023 Asclepius MedTech Ltd. provides a remote patient monitoring platform set to revolutionize pre- and post-operative surgical assessments by unleashing…

Read more

INTRODUCING OUR VENTURE NILOCAS

PRESS RELEASE Amsterdam, 09/10/2023 Nilocas Ltd. provides a medical device that is set to revolutionise the detection of Coronary Artery Disease in a variety…

Read more

Porous nominated for the Innovation Award Berlin Brandenburg

Early detection of osteoporosis: POROUS GmbH is nominated for the Innovation Award Berlin Brandenburg 2023. Osteoporosis is a chronic widespread disease that affects hundreds…

Read more

NLC Announces Crowdfunding Campaign

NLC Announces Crowdfunding Campaign as part of a larger €10 Million financing round, of which €6.5 million already raised   Amsterdam, 01/10/2023— NLC, the…

Read more

TherageniX and University of Nottingham Awarded £995K

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration   – Novel non-viral gene delivery…

Read more

IPD secures funding of €2.1M to initiate its first-in-human trials for prosthetic joint infections

PRESS RELEASE Amsterdam, July 20, 2023 IPD B.V. (Implant Preservation Devices), a Netherlands-based start-up specializing in the treatment of prosthetic joint infections, raised €2.1…

Read more